危重症相关皮质类固醇不足(CIRCI):SCCM与ESICM多学科工作组的叙述性综述
本文为SCCM与ESICM多学科工作组对危重症相关皮质类固醇不足(CIRCI)病理生理学最新概念的叙述性综述,检索了Medline、DARE、CENTRAL和Cochrane系统评价数据库。综述认为CIRCI由三大病理生理事件构成:下丘脑-垂体-肾上腺(HPA)轴失调、皮质醇代谢改变和组织对糖皮质激素抵抗。HPA轴失调涉及CRH/ACTH通路、自主神经系统、血管加压素系统和免疫系统之间的多向交互;近期研究显示危重症时皮质醇血浆清除率显著降低,归因于肝脏和肾脏主要皮质醇代谢酶表达和活性受抑;尽管皮质醇水平升高,组织糖皮质激素抵抗被认为源于糖皮质激素α介导的抗炎活性不足。结论指出,对CIRCI病理生理的新认识增加了当前诊断工具识别高危患者的局限性,也可能影响CIRCI患者糖皮质激素的使用方式。
要点
- CIRCI由三大病理生理事件构成:HPA轴失调、皮质醇代谢改变和组织对糖皮质激素抵抗。
- 危重症时皮质醇血浆清除率显著降低,由肝脏和肾脏主要皮质醇代谢酶表达和活性受抑所致。
- 尽管危重症时皮质醇水平升高,组织糖皮质激素抵抗被认为源于糖皮质激素α介导的抗炎活性不足。
- HPA轴失调涉及CRH/ACTH通路、自主神经系统、血管加压素系统和免疫系统的多向交互。
- 新病理生理认识增加了当前诊断工具识别高危患者的局限性,并可能影响CIRCI患者糖皮质激素的使用方式。
研究设计与关键结果
- 研究类型:叙述性综述;由SCCM与ESICM多学科工作组(国际危重症医学与内分泌学专家)制定;检索Medline、DARE、CENTRAL和Cochrane系统评价数据库。
- CIRCI由三大病理生理事件构成:HPA轴失调、皮质醇代谢改变和组织对糖皮质激素抵抗。
- HPA轴失调复杂,涉及CRH/ACTH通路、自主神经系统、血管加压素系统和免疫系统之间的多向交互。
- 近期研究显示危重症时皮质醇血浆清除率显著降低,由肝脏和肾脏主要皮质醇代谢酶表达和活性受抑所致。
- 尽管危重症时皮质醇水平升高,组织对糖皮质激素抵抗被认为源于糖皮质激素α介导的抗炎活性不足。
证据类型、等级与局限
- 证据类型:叙述性综述(SCCM与ESICM多学科工作组)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对CIRCI病理生理的新认识增加了当前诊断工具识别高危患者的局限性,并可能影响CIRCI患者糖皮质激素的使用方式。
指南或共识出处
- 危重症相关皮质类固醇不足(CIRCI):SCCM与ESICM多学科工作组的叙述性综述(Intensive Care Med)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To provide a narrative review of the latest concepts and understanding of the pathophysiology of critical illness-related corticosteroid insufficiency (CIRCI).
PARTICIPANTS: A multispecialty task force of international experts in critical care medicine and endocrinology and members of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM).
DATA SOURCES: Medline, Database of Abstracts of Reviews of Effects (DARE), Cochrane Central Register of Controlled Trials (CENTRAL) and the Cochrane Database of Systematic Reviews.
RESULTS: Three major pathophysiologic events were considered to constitute CIRCI: dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, altered cortisol metabolism, and tissue resistance to glucocorticoids. The dysregulation of the HPA axis is complex, involving multidirectional crosstalk between the CRH/ACTH pathways, autonomic nervous system, vasopressinergic system, and immune system. Recent studies have demonstrated that plasma clearance of cortisol is markedly reduced during critical illness, explained by suppressed expression and activity of the primary cortisol-metabolizing enzymes in the liver and kidney. Despite the elevated cortisol levels during critical illness, tissue resistance to glucocorticoids is believed to occur due to insufficient glucocorticoid alpha-mediated anti-inflammatory activity.
CONCLUSIONS: Novel insights into the pathophysiology of CIRCI add to the limitations of the current diagnostic tools to identify at-risk patients and may also impact how corticosteroids are used in patients with CIRCI.
参考来源
- Annane D, Pastores SM, Arlt W, et al. Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Med. 2017. PMID: 28940017. doi:10.1007/s00134-017-4914-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。